National Institutes of Health

F.D.A. to Allow ‘Mix and Match’ Approach for Covid Booster Shots

The agency may act this week, when it is expected to authorize booster shots for recipients of the Moderna and Johnson & Johnson vaccines.

Clinical data quashes experimental Covid-19 therapies from Brii, Vir & Apellis

Antibody therapies from Brii Biosciences and Vir Biotechnology failed to show sufficient efficacy to advance to the next stage of an NIH-sponsored Covid-19 clinical trial. Apellis Pharmaceuticals and Durect also stopped work on experimental Covid treatments.

The Covid-19 Vaccine Doesn’t Mean Big Pharma Is Your Savior

Heroic work went into the development of the coronavirus vaccines. But that doesn’t mean this industry deserves your affection.

The Covid-19 Vaccine Doesn’t Mean Big Pharma Is Your Savior

Heroic work went into the development of the coronavirus vaccines. But that doesn’t mean this industry deserves your affection.

Vacuna de Moderna contra el coronavirus: lo que necesitas saber

La revisión positiva probablemente asegure que la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) concederá esta semana la autorización de emergencia para una segunda vacuna contra el coronavirus para millones de estadounidenses.

Vacuna de Moderna contra el coronavirus: lo que necesitas saber

La revisión positiva probablemente asegure que la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) concederá esta semana la autorización de emergencia para una segunda vacuna contra el coronavirus para millones de estadounidenses.

La vacuna de Moderna tiene altos índices de protección contra el coronavirus. ¿Cómo es distinta de la vacuna de Pfizer-BioNTech?

La revisión positiva probablemente asegure que la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) concederá esta semana la autorización de emergencia para una segunda vacuna contra el coronavirus para millones de estadounidenses.

Report: FDA halted move to authorize convalescent plasma for Covid-19 over evidence concerns

The New York Times reported that the FDA was prepared to issue an emergency use authorization for the treatment last week, but NIH Director Francis Collins and NIAID Director Anthony Fauci intervened, arguing that data were too weak.

NIAID launches clinical trial network for preventive drugs, vaccines against Covid-19

The NIAID create the Covid-19 Prevention Trials Network by combining four existing ones, primarily focused on HIV and AIDS, which will continue that work in addition to their new focus on Covid-19.

Time for Policymakers, Hospitals to Bet Big on Home-Based Care

It’s time for policymakers, hospitals and everyone else at the health care roulette table to bet all their chips on proactive, pre-acute home-based care. During the coronavirus pandemic, the U.S. health care system has undergone a massive change marked by the skyrocketing use of telehealth technology and the shift away from brick-and-mortar medical appointments. In …

Time for Policymakers, Hospitals to Bet Big on Home-Based Care Read More »